Your browser doesn't support javascript.
loading
Kynurenine derivative 3-HAA is an agonist ligand for transcription factor YY1.
Shi, Zhaopeng; Gan, Guifang; Xu, Xiang; Zhang, Jieying; Yuan, Yuan; Bi, Bo; Gao, Xianfu; Xu, Pengfei; Zeng, Wenbin; Li, Jixi; Ye, Youqiong; Zhou, Aiwu; Zhang, Naixia; Liu, Wen; Lin, Shuhai; Mi, Jun.
Afiliação
  • Shi Z; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Gan G; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu X; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang J; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yuan Y; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Bi B; Department of Nuclear Medicine, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Gao X; Shanghai Profleader Biotech Co., Ltd, Shanghai, China.
  • Xu P; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Zeng W; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Li J; School of Life Science, Fudan University, Shanghai, China.
  • Ye Y; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhou A; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang N; CAS Key Laboratory of Receptor Research, Department of Analytical Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Liu W; School of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China. w2liu@xmu.edu.cn.
  • Lin S; School of Life Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China. shuhai@xmu.edu.cn.
  • Mi J; Basic Medical Institute, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jmei@sjtu.edu.cn.
J Hematol Oncol ; 14(1): 153, 2021 09 25.
Article em En | MEDLINE | ID: mdl-34563230
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Fator de Transcrição YY1 / Ácido 3-Hidroxiantranílico / Cinurenina / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Fator de Transcrição YY1 / Ácido 3-Hidroxiantranílico / Cinurenina / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China